Digestive & Intestinal Remedies (Pharmacies) - Guinea

Revenue in the Digestives & Intestinal Remedies market is projected to reach US$5.41m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 5.18%, resulting in a market volume of US$6.97m by 2029.
In global comparison, most revenue will be generated China (US$3.37bn in 2024).
In relation to total population figures, per person revenues of US$0.37 are generated in 2024.

Definition:
The Digestives and Intestinal Remedies market encompasses a range of over-the-counter (OTC) natural and synthetic digestive agents and remedies designed to address gastrointestinal concerns. These products are available through pharmacies and are provided in various forms such as pills, powder, capsules, liquids, solutions, suspensions, drops, and suppositories. The market excludes prescription medications, substances contravening state regulations, or items not explicitly categorized as digestive medications (e.g., pain relievers). Notable among the best-selling products in this category are Perenterol, Iberogast, Dulcolax, and Buscopan Plus. This market exclusively covers product sales through pharmacies.

Additional information:
The Digestives and Intestinal Remedies market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Digestive medicines
Remedies against gastrointestinal complaints

Prescription medicines
Homeopathic remedies
Tea

The Digestive & Intestinal Remedies (Pharmacies) market in Guinea is experiencing steady growth due to a combination of customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. Customer preferences in Guinea are driving the demand for digestive and intestinal remedies. As the population becomes more aware of the importance of maintaining a healthy digestive system, there is an increasing demand for over-the-counter remedies that can provide relief from common digestive issues such as indigestion, bloating, and diarrhea. Customers are also seeking natural and herbal remedies as they become more conscious of the potential side effects of traditional medications. Trends in the market are also contributing to the growth of the Digestive & Intestinal Remedies market in Guinea. The rise of e-commerce has made it easier for customers to access a wide range of products, including digestive and intestinal remedies, from the comfort of their own homes. This convenience factor has led to an increase in online sales of these products. Additionally, there is a growing trend towards self-care and self-medication, with customers taking a proactive approach to managing their own health. This trend has further fueled the demand for over-the-counter digestive and intestinal remedies. Local special circumstances in Guinea are also playing a role in the development of the market. The country has a high prevalence of gastrointestinal diseases, which has created a significant market for digestive and intestinal remedies. This, coupled with a lack of access to healthcare facilities in rural areas, has led to an increased reliance on pharmacies for healthcare needs. Pharmacies in Guinea are often the first point of contact for individuals seeking treatment for digestive issues, further driving the demand for these remedies. Underlying macroeconomic factors are also contributing to the growth of the Digestive & Intestinal Remedies market in Guinea. The country's improving economy has led to an increase in disposable income, allowing individuals to spend more on healthcare products. Additionally, the government's efforts to improve healthcare infrastructure and increase access to healthcare services have also contributed to the growth of the market. In conclusion, the Digestive & Intestinal Remedies market in Guinea is experiencing steady growth due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. As the population becomes more health-conscious and seeks convenient and effective remedies for digestive issues, the demand for these products is expected to continue to rise.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.